Harnessing the Diversity of Burkholderia spp. Prophages for Therapeutic Potential
Cells · 2024
DOI: 10.3390/cells13050428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Hayley R Nordstrom und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. Hauptthemen laut MEDLINE: Bacteriophages, Burkholderia, Burkholderia cepacia complex, Burkholderia Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation, Department of Medicine at the University of Pittsburgh School of Medicine.
Abstract (Originalsprache)
Burkholderia spp. are often resistant to antibiotics, and infections with these organisms are difficult to treat. A potential alternative treatment for Burkholderia spp. infections is bacteriophage (phage) therapy; however, it can be difficult to locate phages that target these bacteria. Prophages incorporated into the bacterial genome have been identified within Burkholderia spp. and may represent a source of useful phages for therapy. Here, we investigate whether prophages within Burkholderia spp. clinical isolates can kill conspecific and heterospecific isolates. Thirty-two Burkholderia spp. isolates were induced for prophage release, and harvested phages were tested for lytic activity against the same 32 isolates. Temperate phages were passaged and their host ranges were determined, resulting in four unique phages of prophage origin that showed different ranges of lytic activity. We also analyzed the prophage content of 35 Burkholderia spp. clinical isolate genomes and identified several prophages present in the genomes of multiple isolates of the same species. Finally, we observed that Burkholdera cenocepacia isolates were more phage-susceptible than Burkholderia multivorans isolates. Overall, our findings suggest that prophages present within Burkholderia spp. genomes are a potentially useful starting point for the isolation and development of novel phages for use in phage therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
- Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
- Center for Evolutionary Biology and Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
ORCID-Profile: Vaughn S Cooper
Förderung
- Cystic Fibrosis Foundation
- Department of Medicine at the University of Pittsburgh School of Medicine
Zitieren
APA
Nordstrom, H. R., Griffith, M. P., Rangachar Srinivasa, V., Wallace, N. R., Li, A., Cooper, V. S., Shields, R. K., & Van Tyne, D. (2024). Harnessing the Diversity of Burkholderia spp. Prophages for Therapeutic Potential. Cells. https://doi.org/10.3390/cells13050428
Vancouver
Nordstrom HR, Griffith MP, Rangachar Srinivasa V, Wallace NR, Li A, Cooper VS, et al. Harnessing the Diversity of Burkholderia spp. Prophages for Therapeutic Potential. Cells. 2024. doi:10.3390/cells13050428
BibTeX
@article{Nordstrom2024,
author = {Nordstrom, Hayley R and Griffith, Marissa P and Rangachar Srinivasa, Vatsala and Wallace, Nathan R and Li, Anna and Cooper, Vaughn S and Shields, Ryan K and Van Tyne, Daria},
title = {Harnessing the Diversity of Burkholderia spp. Prophages for Therapeutic Potential},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13050428}
}
EUVIMED